Evidence map›Paper›PMID 28877953›Full record

ArticleJournal of leukocyte biology2017

Anti-inflammatory roles of p38α MAPK in macrophages are context dependent and require IL-10.

Abbas Raza, Jessica W Crothers, Mahalia M McGill, Gary M Mawe, Cory Teuscher, Dimitry N Krementsov

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Effect and Mechanism of Corilagin fromFoods (Basel, Switzerland) · 2023
    Article
  13. Emerging role of protein modification in inflammatory bowel disease.Journal of Zhejiang University. Science. B · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Macrophages augment the skeletal muscle proinflammatory response through TNFα following LPS-induced acute lung injury.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abbas RazaDivision of Immunobiology, Department of Medicine, College of Medicine, University of Vermont, Burlington, Vermont, USA.
Jessica W CrothersDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Vermont, Burlington, Vermont, USA; and.
Mahalia M McGillDepartment of Medical Laboratory and Radiation Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, Vermont, USA.
Gary M MaweDepartment of Neurological Sciences, College of Medicine, University of Vermont, Burlington, Vermont, USA.
Cory TeuscherDivision of Immunobiology, Department of Medicine, College of Medicine, University of Vermont, Burlington, Vermont, USA.
Dimitry N KrementsovDepartment of Medical Laboratory and Radiation Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, Vermont, USA dkrement@uvm.edu.
University of Vermont · USUniversity of Vermont Medical Center · US

Funding

Neuronal Excitability and Motility in ColitisR01DK062267 · NIDDK · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI MAWE, GARY M · 2002 to 2016
$3.3M
H1R Signaling and Immune Deviation in EAER01NS069628 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2010 to 2014
$1.6M
Genome-Wide Physical Mapping of IAV-QTL in Wild-Derived Inbred MiceR21AI128595 · NIAID · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2017 to 2018
$428k
Gene-Environment Interactions in CNS Autoimmune DiseaseR21NS095007 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2016 to 2017
$427k
p38 MAPK as a female-specific druggable target in CNS autoimmune diseaseR21NS076200 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2011 to 2012
$419k
NIAID NIH HHS R21 AI128595NIDDK NIH HHS R01 DK062267NINDS NIH HHS R01 NS069628NINDS NIH HHS R21 NS076200NINDS NIH HHS R21 NS095007
6 · The paper itself

Abstract

The p38 MAPK pathway was originally identified as a master regulator of proinflammatory cytokine production by myeloid cells. Numerous drugs targeting this kinase showed promise in preclinical models of inflammatory disease, but so far, none have shown efficacy in clinical trials. The reasons behind this are unclear, but may, in part, be explained by emerging anti-inflammatory functions of this kinase or overly refined selectivity of second-generation pharmacologic inhibitors. Here, we show that p38α signaling in macrophages plays pro- and anti-inflammatory functions in vivo and in vitro, with the outcome depending on the stimulus, output, kinetics, or mode of kinase inhibition (genetic vs. pharmacologic). Different pharmacologic inhibitors of p38 exhibit opposing effects, with second-generation inhibitors acting more specifically but inhibiting anti-inflammatory functions. Functionally, we show that the anti-inflammatory functions of p38α in macrophages are critically dependent on production of IL-10. Accordingly, in the absence of IL-10, inhibition of p38α signaling in macrophages is protective in a spontaneous model of colitis. Taken together, our results shed light on the limited clinical efficacy of drugs targeting p38 and suggest that their therapeutic efficacy can be significantly enhanced by simultaneous modulation of p38-dependent anti-inflammatory mediators, such as IL-10.

Indexed as

AnimalsAnti-Inflammatory AgentsColitisFemaleGene Expression RegulationHumansImmunologic FactorsInterleukin-10Interleukin-6LipopolysaccharidesMacrophagesMaleMiceMice, Transgenicp38 Mitogen-Activated Protein KinasesPrimary Cell CultureAnti-Inflammatory AgentsIL10 protein, mouseImmunologic FactorsInterleukin-10Interleukin-6interleukin-6, mouseLipopolysaccharidesp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsTumor Necrosis Factor-alphaautoimmunitycolitisdrugIBDpharmacologic inhibitor

Identifiers

PMID28877953
PMCPMC6608039
OpenAlexW2753473930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.